bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) rose 20.6% during trading on Thursday . The stock traded as high as $0.34 and last traded at $0.34. Approximately 1 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 1,833 shares. The stock had previously closed at $0.2819.
bioAffinity Technologies Stock Performance
The firm’s 50 day moving average price is $0.30 and its two-hundred day moving average price is $0.25.
bioAffinity Technologies Company Profile
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
Featured Stories
- Five stocks we like better than bioAffinity Technologies
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump’s AI Secret: 100X Faster Than Nvidia
- Trump Planning to Use Public Law 63-43: Prepare Now
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
